Who is sponsoring NCT03678714?

NCT03678714 is sponsored by Sheffield Hallam University.

What drugs are being tested in NCT03678714?

Interventions in NCT03678714: Exercise Intervention, Lifestyle Physical Activity.

What condition does NCT03678714 study?

NCT03678714 studies Polycystic Ovary Syndrome.

Is NCT03678714 still recruiting?

NCT03678714 is currently completed. Last updated 29 October 2020.

Last reviewed 2020-10-29 · How we verify

NCT03678714

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Exercise on Cardiometabolic Profile in Women With Polycystic Ovary Syndrome

Completed NA Last updated 29 October 2020

What this trial tests

NA trial testing Exercise Intervention in Polycystic Ovary Syndrome in 37 participants. Completed in 30 May 2020.

Timeline

1 October 2018

Primary endpoint
30 April 2020

30 May 2020

Quick facts

Lead sponsor	Sheffield Hallam University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	37
Start date	1 October 2018
Primary completion	30 April 2020
Estimated completion	30 May 2020
Sites	1 location across United Kingdom

Drugs / interventions tested

Exercise Intervention
Lifestyle Physical Activity

Conditions studied

Polycystic Ovary Syndrome — all drugs for Polycystic Ovary Syndrome →

Sponsor

Sheffield Hallam University

Who can join

Adults 18 to 50, female only, with Polycystic Ovary Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Polycystic Ovary Syndrome (PCOS) is a complex hormonal and metabolic disorder that has been shown to affect women's fertility. It can also share many symptoms with pre-diabetes, and women with PCOS often have an increased risk for type 2 diabetes, heart attack and stroke. This study aims to assess the feasibility and acceptability of exercise intervention and increased lifestyle physical activity to improve cardiovascular disease risk factors in women with PCOS.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Supervised exercise training and increased physical activity to reduce cardiovascular disease risk in women with polycystic ovary syndrome: study protocol for a randomized controlled feasibility trial.
Woodward A, Broom D, Dalton C, Metwally M, et al · · 2020 · cited 4× · PMID 31959233 · DOI 10.1186/s13063-019-3962-7

Verify or expand the search:

Other trials of Exercise Intervention

Trials testing the same drug.

NCT07474090 — Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial · NA · not yet recruiting
NCT06565260 — Community-Based Exercise and Nutrition Training and Education Program for Cancer Survivors · NA · recruiting
NCT07302230 — Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Amon · NA · recruiting
NCT07340281 — Biomarkers for Exercise · NA · recruiting
NCT07504835 — GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer · NA · not yet recruiting

Other recruiting trials for Polycystic Ovary Syndrome

Currently open trials in the same condition.

NCT07591246 — Efficay of Physical Activity Program in PCOS Females With Fatty Pancrease and Thyroid Hypofunction · NA · recruiting
NCT07446985 — Is There a Benefit From Addition of Physical Exercise to Diet Restriction/Limitation in PCOS Women With Asthma? · NA · recruiting
NCT07385716 — Evaluation of the Effect of Time-Restricted Feeding and Mediterranean Diet Model in Women With Polycystic Ovary Syndrome · NA · recruiting
NCT07366944 — PCOS and Problem of Eye Dryness: Is There a Benefit From Lifetyle Changes · NA · recruiting
NCT07289399 — Is There a Benefit From Addition of Treadmill Walking to Diet Restriction in Psoriasis Women With PCOS? · NA · recruiting

Other Sheffield Hallam University trials

Trials by the same sponsor.

NCT07373483 — Observing 3-5 Year Old Children's Use of Interactive Electronic Devices (IED) in the Family Home to Understand the Conte · recruiting
NCT07585474 — Gut Microbiome Response to Long-Haul Travel in Elite Football Players · NA · enrolling by invitation
NCT06810570 — The Effect of Mobile Devices on the Development and Health of Young Children · recruiting
NCT06094517 — What Are Persistent Lower Back Pain Patients' Views of Sleep Health Within an Outpatient Musculoskeletal Physiotherapy S · unknown
NCT06101875 — Health Coaching for Patients Waiting for Hip or Knee Replacements · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03678714 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sheffield Hallam University
Last refreshed: 29 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03678714.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing